相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Blood-Brain Barrier Permeability and Gadolinium Benefits and Potential Pitfalls in Research
Axel Montagne et al.
JAMA NEUROLOGY (2016)
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
Axel Montagne et al.
NEURON (2015)
Blood-brain barrier impairment in dementia: Current and future in vivo assessments
Harm J. van de Haar et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
Longitudinal assessment of blood-brain barrier leakage during epileptogenesis in rats. A quantitative MRI study
E. A. van Vliet et al.
NEUROBIOLOGY OF DISEASE (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Vascular alterations in PDAPP mice after anti-Aβ immunotherapy: Implications for amyloid-related imaging abnormalities
Wagner Zago et al.
Alzheimers & Dementia (2013)
Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease
Michelle A. Erickson et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Development, maintenance and disruption of the blood-brain barrier
Birgit Obermeier et al.
NATURE MEDICINE (2013)
Blood-Brain Barrier Permeability of Normal Appearing White Matter in Relapsing-Remitting Multiple Sclerosis
Henrik Lund et al.
PLOS ONE (2013)
Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?
Jens Moreth et al.
IMMUNITY & AGEING (2013)
Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
Susanne Ostrowitzki et al.
ARCHIVES OF NEUROLOGY (2012)
Neutralization of Soluble, Synaptotoxic Amyloid β Species by Antibodies Is Epitope Specific
Wagner Zago et al.
JOURNAL OF NEUROSCIENCE (2012)
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Reisa Sperling et al.
LANCET NEUROLOGY (2012)
Use of Contrast Media in Neuroimaging
Marco Essig et al.
MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA (2012)
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer's Association Research Roundtable Workgroup
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
Noninvasive Magnetic Resonance Imaging Detection of Cerebral Amyloid Angiopathy-Related Microvascular Alterations Using Superparamagnetic Iron Oxide Particles in APP Transgenic Mouse Models of Alzheimer's Disease: Application to Passive Aβ Immunotherapy
Nicolau Beckmann et al.
JOURNAL OF NEUROSCIENCE (2011)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Blood-Brain Barrier Permeability Abnormalities in Vascular Cognitive Impairment
Saeid Taheri et al.
STROKE (2011)
A Single Ascending Dose Study of Bapineuzumab in Patients With Alzheimer Disease
Ronald S. Black et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2010)
Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid beta-peptide elimination from the brain
Berislav V. Zlokovic et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Immunotherapy, Vascular Pathology, and Microhemorrhages in Transgenic Mice
Donna M. Wilcock et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Cerebral microbleeds: a guide to detection and interpretation
Steven M. Greenberg et al.
LANCET NEUROLOGY (2009)
Evolution of the neocortex: a perspective from developmental biology
Pasko Rakic
NATURE REVIEWS NEUROSCIENCE (2009)
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
S. Salloway et al.
NEUROLOGY (2009)
Consequence of A immunization on the vasculature of human Alzheimers disease brain
D. Boche et al.
BRAIN (2008)
Immunotherapy reduces vascular amyloid-β in PDAPP mice
Sally Schroeter et al.
JOURNAL OF NEUROSCIENCE (2008)
Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease
Roy O. Weller et al.
BRAIN PATHOLOGY (2008)
Aβ vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease
E Masliah et al.
NEUROLOGY (2005)
MRI measurement of blood-brain barrier permeability following spontaneous reperfusion in the starch microsphere model of ischemia
NG Harris et al.
MAGNETIC RESONANCE IMAGING (2002)
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
C Janus et al.
NATURE (2000)
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
D Morgan et al.
NATURE (2000)
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F Bard et al.
NATURE MEDICINE (2000)
分享论文
